{"id":139,"date":"2025-09-02T01:00:00","date_gmt":"2025-09-02T01:00:00","guid":{"rendered":"https:\/\/cninmed.com\/en\/?p=139"},"modified":"2025-09-02T07:02:00","modified_gmt":"2025-09-02T07:02:00","slug":"china-bd-2025-novatim-and-radiance-enters-a-1-billion-usd-license-on-met-egfr-bsadc-ky-0301","status":"publish","type":"post","link":"https:\/\/cninmed.com\/en\/2025\/139.html","title":{"rendered":"[China BD 2025] Novatim and Radiance enters a 1 billion USD license on MET\/EGFR BsADC KY-0301"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Announced Date: 2025-08-29 (August 29, 2025)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Name: KY-0301<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensor: Novatim (Novatim Immune Therapeutics, China)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Licensee (Buyer): Radiance (Radiance Biopharma, US)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Modality:   BsADC (bispecific antibody drug conjugate)\u00a0, nanobody<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Asset Target: MET\/EGFR<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Potential Indication: solid tumors<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Current Stage: Phase I, in China<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Scope of Authority: &nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Novatim has granted Radiance exclusive worldwide rights (excluding\u00a0China\u2019s\u00a0mainland,\u00a0Hong Kong,\u00a0Macao\u00a0and\u00a0Taiwan\u00a0region) to develop and commercialize KY-0301.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Deal Detail:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Upfront payment of $15 million,<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Development and regulatory milestone payments up to \u00a0$150 million;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sales milestone payments of up to $1 billion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Total up to $1.165 billion.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Tiered royalties on net sales.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Link:  <a href=\"https:\/\/mp.weixin.qq.com\/s\/HgSEGXSBvWBwLMopPVa2ug\">https:\/\/mp.weixin.qq.com\/s\/HgSEGXSBvWBwLMopPVa2ug<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Announced Date: 2025-08-29 (August 29, 2025) Asset Name: KY-0301 Licensor: Novatim (Novatim Immune Therapeutics, China) Licensee &hellip; <a title=\"[China BD 2025] Novatim and Radiance enters a 1 billion USD license on MET\/EGFR BsADC KY-0301\" class=\"hm-read-more\" href=\"https:\/\/cninmed.com\/en\/2025\/139.html\"><span class=\"screen-reader-text\">[China BD 2025] Novatim and Radiance enters a 1 billion USD license on MET\/EGFR BsADC KY-0301<\/span>Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-139","post","type-post","status-publish","format-standard","hentry","category-china-license-out"],"_links":{"self":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/comments?post=139"}],"version-history":[{"count":1,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/139\/revisions"}],"predecessor-version":[{"id":140,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/posts\/139\/revisions\/140"}],"wp:attachment":[{"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/media?parent=139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/categories?post=139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cninmed.com\/en\/wp-json\/wp\/v2\/tags?post=139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}